The majority of hepatocellular carcinomas arise in background chronic liver disease, particularly cirrhosis. The pathogenesis of noncirrhotic hepatocellular carcinomas remains unclear. While malignant ...

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...

Please provide your email address to receive an email when new articles are posted on . The 70-year-old patient had initially presented with rectal bleeding. Colonoscopy revealed a large ulcerated, ...